Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,010.31 -4.18 (-0.41%)

Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Biotech Valuations Rise as New Clinical Platforms Show Progress

November 24, 2025

Via Investor Brand Network

Biotech Valuations Rise as New Clinical Platforms Show Progress

November 24, 2025

From BioMedWire

Via GlobeNewswire

Eli Lilly Joins Tech Players In The $1T Market Capitalization Club ↗

November 21, 2025

The company’s GLP-1 drugs, Zepbound and Mounjaro, have driven investor appetite and pushed its share price by about 40% this year.

Via Stocktwits

Novo Nordisk Dives As Ozempic Fails To Slow Alzheimer's; Lilly Falls, Biogen Jumps ↗

November 24, 2025

Eli Lilly fell while Biogen jumped.

Via Investor's Business Daily

Eli Lilly & Co (NYSE:LLY) Presents a Compelling Case for Growth at a Reasonable Price ↗

November 24, 2025

Eli Lilly (LLY) presents strong growth at a reasonable price (GARP), with accelerating earnings and revenue supported by top-tier profitability.

Via Chartmill

1 Spectacular Warren Buffett-Approved Index Fund That Could Turn $500 Per Month Into $1 Million ↗

November 24, 2025

Investing in an S&P 500 index fund can be a great way to build long-term wealth.

Via The Motley Fool

Topics ETFs Economy Stocks

Wall Street Rebounds—but Confidence Remains on a Short Leash ↗

November 24, 2025

After a bruising week, Wall Street regained its footing on Friday as rate-cut hopes resurfaced and fears around the AI sell-off eased, if only slightly. Solid PMI data and improving inflation...

Via Chartmill

Topics Artificial Intelligence Economy

Madrigal Pharma Stock Sees Buyout Hype – Retail Predicts ‘Huge’ Deal On Liver Disease Drug Momentum ↗

November 24, 2025

Fresh analyst target hikes followed new two-year clinical data showing sustained improvements in key liver-health measures.

Via Stocktwits

Q3 Earnings Outperformers: Merck (NYSE:MRK) And The Rest Of The Branded Pharmaceuticals Stocks

November 23, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Merck (NYSE:MRK) and the best and worst...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Billionaire Stanley Druckenmiller Dropped Nvidia, Palantir, and Eli Lilly Over the Past Year and Just Bought the 2 Cheapest Magnificent Seven Stocks. ↗

November 23, 2025

These Magnificent Seven players are well-positioned to benefit in the AI boom.

Via The Motley Fool

Topics Artificial Intelligence

2 Top Dividend Stocks for Growth-Oriented Investors ↗

November 23, 2025

Who says you have to choose between the two?

Via The Motley Fool

Topics Artificial Intelligence

Novo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant? ↗

November 23, 2025

The obesity drug producer has taken some hits throughout the past year, but it is beginning to punch back.

Via The Motley Fool

Topics Government

2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026? ↗

November 22, 2025

Many other drugmakers are attempting to break this duopoly, but this may not happen anytime soon.

Via The Motley Fool

3 Top Dividend Stocks to Buy in November ↗

November 22, 2025

November is a great month to be thankful for opportunities to invest in these fantastic companies.

Via The Motley Fool

Topics Bonds Economy

How To Play Eli Lilly Stock As It Hits A Much-Anticipated Milestone? ↗

November 21, 2025

Eli Lilly stock has already rallied 70% in less than four months.

Via Talk Markets

A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves ↗

November 21, 2025

Via MarketBeat

Topics Artificial Intelligence

Eli Lilly Stock Just Joined the $1 Trillion Club. Should You Buy LLY Here?

November 21, 2025

Eli Lilly stock inches higher as the company joins the coveted trillion-dollar club. Citi analysts believe LLY shares will push meaningfully higher in 2026.

Via Barchart.com

Topics Government

Eli Lilly Breaks $1 Trillion Barrier, A First For The Healthcare Industry ↗

November 21, 2025

Eli Lilly hit a $1 trillion valuation for the first time, becoming the only healthcare company to reach the milestone as demand for its weight-loss drugs continues to surge.

Via Talk Markets

Eli Lilly Stock Is Rising Today: Here's What You Need To Know ↗

November 21, 2025

Eli Lilly and Co (NYSE:LLY) shares are trading higher on Friday. The company plans to start selling its obesity drug through a new approach aimed at expanding access.

Via Benzinga

The AI Valuation Conundrum: Is the Market Inflating a Bubble or Fueling a Revolution?

November 21, 2025

Concerns are mounting across financial markets regarding a potential "AI bubble," as sky-high valuations for technology companies, particularly those focused on artificial intelligence, trigger...

Via TokenRing AI

Topics Artificial Intelligence Economy Fraud

Eli Lilly Becomes First Pharma To Join $1 Trillion Club Alongside Nvidia, Apple, Others ↗

November 21, 2025

Eli Lilly became the first health care company to top $1 trillion in market capitalization on Friday.

Via Investor's Business Daily

Eli Lilly Stock Joins the $1 Trillion Club as LLY Hits New All-Time Highs

November 21, 2025

Eli Lilly (LLY) just became the first healthcare company to join the $1 trillion market cap club. Shares are trading at a new all-time high on Friday, Nov. 21. The stock is up 40% in the past year and...

Via Barchart.com

Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)

November 21, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Supernus Pharmaceuticals (NASDAQ:SUPN) and...

Via StockStory

Topics Artificial Intelligence Intellectual Property

What's Going On With Novo Nordisk Stock? ↗

November 21, 2025

The management team conducted a cost-cutting effort that is likely to result in a more efficient business.

Via The Motley Fool

KeyCorp Delivers Sobering Outlook for LifeMD, Slashing Price Target Amidst Operational Headwinds

November 20, 2025

KeyCorp, through its KeyBanc capital markets division, has issued a significantly more pessimistic forecast for LifeMD (NASDAQ: LFMD) stock, dramatically lowering its price objective to $8.00 from a...

Via MarketMinute

Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday ↗

November 20, 2025

Via Benzinga

Novo Nordisk Just Made a Big Move in the Weight Loss Drug Market. Should You Worry About Rival Eli Lilly? ↗

November 20, 2025

Novo Nordisk just addressed a problem that has prevented some from taking these drugs.

Via The Motley Fool

Correction and Clarification: Trifecta and Edward Fruitman, M.D., Do Not Maintain Any Contractual Relationship or Product Preference With Eli Lilly or LillyDirect®

November 20, 2025

November 20, 2025 -- The organization reiterates it has no partnership with Lilly and does not endorse or favor Eli Lilly products, including Zepbound®, in its weight-loss and medical services.

Via 24-7 Press Release

HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗

November 19, 2025

Via MarketBeat

Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

November 19, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Eli Lilly (NY:LLY)

All News about Eli Lilly

Starting at $3.75/week.

Subscribe Today